Advertisement

Reactions Weekly

, Volume 1744, Issue 1, pp 5–5 | Cite as

New nitrosamine impurity detected in losartan tablets

News item
  • 22 Downloads

Reference

  1. US Food and Drug Administration. FDA provides update on its ongoing investigation into ARB drug products; reports on finding of a new nitrosamine impurity in certain lots of losartan and product recall. Internet Document : 1 Mar 2019. Available from: URL: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm632425.htm

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations